Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Heart Failure

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Heart Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonopoulou, S; Chrysohoou, C; Detopoulou, P; Fragopoulou, E; Kotroyiannis, I; Nomikos, T; Panagiotakos, DB; Pitsavos, C; Stefanadis, C; Vassiliadou, C2
Antonopoulou, S; Chrysohoou, C; Detopoulou, P; Fragopoulou, E; Nomikos, T1
Chello, M; Mastroroberto, P; Perticone, F1
Fukui, K; Koyama, M; Munakata, M; Ono, Y; Satoh, K; Suzuki, S1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Heart Failure

ArticleYear
Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.
    Current heart failure reports, 2013, Volume: 10, Issue:2

    Topics: Animals; Atherosclerosis; Cardiotonic Agents; Disease Progression; Drug Design; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Ischemia; Platelet Activating Factor

2013

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Heart Failure

ArticleYear
Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.
    Clinical biochemistry, 2009, Volume: 42, Issue:1-2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Aged; Diacylglycerol Cholinephosphotransferase; Heart Failure; Humans; Leukocytes; Male; Middle Aged; Platelet Activating Factor

2009
Baseline and 6-Week follow-up levels of PAF and activity of its metabolic enzymes in patients with heart failure and healthy volunteers--a pilot study.
    Angiology, 2013, Volume: 64, Issue:7

    Topics: Acetyltransferases; Aged; Biomarkers; Diacylglycerol Cholinephosphotransferase; Follow-Up Studies; Heart Failure; Humans; Leukocytes; Male; Middle Aged; Pilot Projects; Platelet Activating Factor

2013
Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis.
    Scandinavian journal of thoracic and cardiovascular surgery, 1996, Volume: 30, Issue:2

    Topics: Atrial Function; Blood Pressure; Case-Control Studies; Echocardiography, Doppler, Color; Embolism; Fibrin Fibrinogen Degradation Products; Heart Diseases; Heart Failure; Heart Valve Prosthesis; Hemostasis; Humans; Ischemic Attack, Transient; Linear Models; Middle Aged; Mitral Valve; Platelet Activating Factor; Pulmonary Artery; Stroke Volume; Systole; Thrombosis; Ventricular Function, Left; Ventricular Pressure; von Willebrand Factor

1996
Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure.
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2000, Volume: 48, Issue:2

    Topics: Animals; Antithrombins; Benzamidines; Dogs; Guanidines; Heart Failure; Heart-Assist Devices; Hemofiltration; Platelet Activating Factor; Protease Inhibitors; Ventricular Function, Left

2000